We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




First Ever International Criteria Lays Foundation for Improved Diagnostic Imaging of Brain Tumors

By MedImaging International staff writers
Posted on 05 Jan 2024
Print article
Image: A research team has drawn up criteria for PET-based examinations of malignant brain tumors (Photo courtesy of 123RF)
Image: A research team has drawn up criteria for PET-based examinations of malignant brain tumors (Photo courtesy of 123RF)

Diffuse gliomas, which are aggressive malignant brain tumors originating from glial cells, present significant treatment challenges. Standard magnetic resonance imaging (MRI) techniques do not adequately capture the complexity of diffuse gliomas. Instead, amino acid positron emission tomography (PET) has become a crucial tool in diagnosing these tumors. This method utilizes protein-based tracers (amino acids) that accumulate in brain tumors, offering more accurate insights into the activity and extent of gliomas. Despite its extensive use in neuro-oncology for years, amino acid PET had not undergone systematic evaluation, and unlike MRI diagnostics, there have been no established criteria for interpreting these PET images.

Now, the international Response Assessment in Neuro-Oncology (RANO) Working Group, guided by experts from Ludwig Maximilian University of Munich (LMU, Munich, Germany) and the Medical University of Vienna (Vienna, Austria), has introduced the first-ever global standards for gliomas imaging using amino acid PET. The RANO Working Group, a diverse international consortium with a decade-long history of developing criteria to serve as standard references for brain tumor-related clinical studies, has made significant strides in assessing various critical clinical aspects.

The RANO group has formulated PET RANO 1.0, a set of criteria aimed at evaluating the effectiveness of treatments for diffuse gliomas using PET. These PET-based standards usher in novel avenues for the uniform assessment of diffuse gliomas. The researchers believe that these new criteria not only facilitate the use of PET in clinical trials and routine practice but also lay a solid groundwork for future investigations, fostering the comparison and enhancement of treatment modalities for better therapeutic outcomes.

Related Links:
LMU
Medical University of Vienna

New
Gold Member
X-Ray QA Meter
T3 AD Pro
1.5T Superconducting MRI System
uMR 680
Ultrasound Color LCD
U156W
1.5T MRI Scanner
MAGNETOM Amira

Print article

Channels

MRI

view channel
Image: A new paradigm in radiation therapy planning aims to improve treatment outcomes for children with brain tumors (Photo courtesy of 123RF)

AI Software Uses MRI Scans to Automatically Segment Key Brain Structures for Improved Radiation Therapy Planning

Advances in radiation therapy have led to significant innovations in the treatment of brain tumors in children, focusing on precision to minimize damage to surrounding healthy brain tissue.... Read more

Ultrasound

view channel
Image: An example of a conventional ultrasound B-scan showing a suspicious breast lesion (left image) and with the new H-scan analysis showing the possibly malignant mass in color (right image) (Photo courtesy of Jihye Baek)

New Ultrasound Technologies Improve Diagnosis for Cancer, Liver Disease and Other Pathologies

Several diseases, including some cancers, can remain hidden or difficult to detect using traditional medical imaging. However, new technologies developed by researchers may soon enhance ultrasound's effectiveness... Read more

Nuclear Medicine

view channel
Image: A new biomarker makes it easier to distinguish between Alzheimer’s and primary tauopathy (Photo courtesy of Shutterstock)

Diagnostic Algorithm Distinguishes Between Alzheimer’s and Primary Tauopathy Using PET Scans

Patients often present at university hospitals with diseases so rare and specific that they are scarcely recognized by physicians in private practice. Primary 4-repeat tauopathies are a notable example.... Read more

General/Advanced Imaging

view channel
Image: The AI tool predicts stroke outcomes after arterial clot removal with 78% accuracy (Photo courtesy of Adobe Stock)

AI Tool Accurately Predicts Stroke Outcomes After Arterial Clot Removal Using CTA Scans

In current stroke treatment protocols, advanced imaging techniques, particularly Computed Tomography Angiography (CTA), play a vital role in determining the management strategy for Large Vessel Occlusion (LVO).... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.